Accumulating evidence has demonstrated that CDKN2B-AS1 is upregulated in a variety of human cancers, such as bladder, gastric, and breast cancers, and serves as an oncogene that plays important roles in tumor progression19. This evidence concerns the gene CDKN2B and breast cancer.